Chinkers M, Garbers D L
J Biol Chem. 1986 Jun 25;261(18):8295-7.
Epidermal growth factor (EGF) receptor protein kinase activity, estimated by the use of peptide substrates, was reduced by as much as 70% after the treatment of intact A431 human carcinoma cells with EGF. The apparent decrease in protein kinase activity was observed after immunoprecipitation of the receptor or after purification of the receptor by lectin chromatography. By the use of [35S]methionine, it was determined that the total amount of receptor obtained was the same whether or not cells were treated with EGF. EGF stimulated the purified receptor protein kinase activity in vitro; however, the EGF-stimulated activity of receptor from EGF-treated cells continued to be reduced by as much at 70% compared to the EGF-stimulated activity from untreated cells. The reduction in receptor protein kinase activity induced by EGF may represent a feedback mechanism by which responsiveness to the growth factor is regulated.
用肽底物估算,在用表皮生长因子(EGF)处理完整的人A431癌细胞后,表皮生长因子(EGF)受体蛋白激酶活性降低了多达70%。在用凝集素色谱法纯化受体后或对受体进行免疫沉淀后,均观察到蛋白激酶活性明显下降。通过使用[35S]甲硫氨酸确定,无论细胞是否用EGF处理,获得的受体总量相同。EGF在体外刺激纯化的受体蛋白激酶活性;然而,与未处理细胞的EGF刺激活性相比,来自EGF处理细胞的受体的EGF刺激活性持续降低多达70%。EGF诱导的受体蛋白激酶活性降低可能代表一种反馈机制,通过该机制调节对生长因子的反应性。